Insider · CIK 0001645600

HANNAH ALISON L.

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001645600

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-08	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+24.4K sh	—	—	35,025
2026-05-15	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+5,750 sh	—	—	16,375
2025-06-01	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.3K sh	—	—	131,023
2025-06-01	NEONEOGENOMICS INCA Award	Director	AAward	+12.3K sh	—	—	131,023
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−12.3K sh	—	—	0
2025-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+16.1K sh	—	—	16,107
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+23.1K sh	—	—	23,077
2025-05-23	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+2,500 sh	—	—	10,625
2025-05-23	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+3,000 sh	—	—	3,000
2024-08-10	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	—	—	118,769
2024-08-10	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2024-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+8,672 sh	—	—	8,672
2024-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+12.3K sh	—	—	12,254
2024-05-25	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+25K sh	—	—	81,250
2024-05-25	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+30K sh	—	—	30,000
2023-08-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+8,353 sh	—	—	8,353
2023-08-10	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+11.3K sh	—	—	11,336
2023-05-26	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+25K sh	—	—	56,250
2023-05-26	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+30K sh	—	—	30,000
2022-07-20	CTMXCytomX Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,602 sh	$1.42	−$7,965.484	31,898
2022-07-19	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+15K sh	—	—	37,500
2022-06-10	NEONEOGENOMICS INCA Award	Director	AAward	+15.6K sh	—	—	107,433
2022-06-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,882
2022-05-20	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+25K sh	—	—	31,250
2022-05-20	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+30K sh	—	—	30,000
2022-02-02	CTMXCytomX Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+22.5K sh	—	—	22,500
2022-02-02	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+135K sh	—	—	135,000
2021-10-24	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2021-10-24	CTMXCytomX Therapeutics, Inc. · Performance Stock Units (PSUs)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2021-06-02	NEONEOGENOMICS INCA Award	Director	AAward	+3,081 sh	—	—	91,877
2021-06-02	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+3,714 sh	—	—	3,714
2021-05-19	RIGLRIGEL PHARMACEUTICALS INCA Award	EVP, Chief Medical Officer	AAward	+6,250 sh	—	—	6,250
2021-05-19	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+7,500 sh	—	—	7,500
2021-05-14	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Chief Medical Officer	AAward	+80K sh	—	—	80,000
2021-02-26	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+175K sh	—	—	175,000
2020-08-06	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.27	+$72.7K	88,796
2020-08-06	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2020-05-28	NEONEOGENOMICS INCA Award	Director	AAward	+2,698 sh	—	—	78,796
2020-05-28	NEONEOGENOMICS INC · Stock Options (Right to Buy)A Award	Director	AAward	+3,448 sh	—	—	3,448
2020-02-03	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+250K sh	—	—	250,000
2019-09-09	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$6.66	+$22.2K	67,765
2019-09-09	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+8,333 sh	$9.11	+$75.9K	76,098
2019-09-09	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	$6.66	−$22.2K	0
2019-09-09	NEONEOGENOMICS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,333 sh	$9.11	−$75.9K	0
2019-06-06	NEONEOGENOMICS INCA Award	Director	AAward	+3,419 sh	—	—	64,432
2019-06-06	NEONEOGENOMICS INC · Stock Options (Right to Buy)A Award	Director	AAward	+4,269 sh	—	—	4,269
2018-06-01	NEONEOGENOMICS INCA Award	Director	AAward	+15.6K sh	—	—	61,013
2018-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+3,017 sh	—	—	3,017
2017-08-09	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,667 sh	$6.66	+$44.4K	45,449
2017-08-09	NEONEOGENOMICS INC · Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−6,667 sh	$6.66	−$44.4K	3,333

Recent filings

Accepted (ET)
Jul 104
HANNAH ALISON L.0000905148-26-003238
SEC(opens sec.gov)
May 194
HANNAH ALISON L.0000905148-26-002531
SEC(opens sec.gov)
Jun 34
HANNAH ALISON L.0001077183-25-000126
SEC(opens sec.gov)
Jun 34/A
HANNAH ALISON L.0001077183-25-000132
SEC(opens sec.gov)
May 284
HANNAH ALISON L.0000905148-25-001932
SEC(opens sec.gov)
Aug 134
HANNAH ALISON L.0001077183-24-000127
SEC(opens sec.gov)
Jun 44
HANNAH ALISON L.0001077183-24-000092
SEC(opens sec.gov)
May 294
HANNAH ALISON L.0000905148-24-001652
SEC(opens sec.gov)
Aug 144
HANNAH ALISON L.0001077183-23-000121
SEC(opens sec.gov)
Jul 124
HANNAH ALISON L.0001140361-23-034282
SEC(opens sec.gov)
Jul 214
HANNAH ALISON L.0001567619-22-014297
SEC(opens sec.gov)

Companies

Address

RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080